Clinical Trial: Efficacy Study of Sodium Channel Blocker in LQT3 Patients

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Ranolazine in LQT3 Patients

Brief Summary: The purpose of this study is to determine whether late sodium channel blockade might be effective in shortening the QTc interval in various LQT3 mutations and be considered as a safe therapeutic option for LQT3 patients.